• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从甲状腺细胞病理学报告的 Bethesda 系统中删除“意义不明确的非典型/滤泡性病变”类别。

Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.

机构信息

Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

出版信息

Am J Clin Pathol. 2011 Dec;136(6):896-902. doi: 10.1309/AJCPIX52MBOKTICP.

DOI:10.1309/AJCPIX52MBOKTICP
PMID:22095375
Abstract

The "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS)" category in the Bethesda System for Reporting Thyroid Cytology is heterogeneous and includes both specimens with borderline cellularity/compromised quality and those with genuine atypia. We have used a reporting scheme that is similar to the Bethesda System but does not include an AUS/FLUS category. We retrospectively reviewed all reports on thyroid FNA and thyroidectomy specimens submitted to the Beth Israel Deaconess Medical Center from January 2006 to December 2008. The positive predictive values for various categories and subcategories in this scheme demonstrate that the AUS/FLUS category can be eliminated to provide information for the most appropriate management of patients with thyroid nodules.

摘要

在甲状腺细胞病理学报告的 Bethesda 系统中,“意义不明确的非典型性/滤泡性病变意义不明确(AUS/FLUS)”这一类别具有异质性,其中既包括细胞界限模糊/质量欠佳的标本,也包括真正意义上的不典型性标本。我们采用了一种类似于 Bethesda 系统但不包括 AUS/FLUS 类别的报告方案。我们对 2006 年 1 月至 2008 年 12 月间提交给 Beth Israel Deaconess Medical Center 的所有甲状腺细针穿刺抽吸(FNA)和甲状腺切除术标本的报告进行了回顾性研究。该方案中各分类和亚分类的阳性预测值表明,可以排除 AUS/FLUS 类别,为甲状腺结节患者的最佳管理提供信息。

相似文献

1
Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.从甲状腺细胞病理学报告的 Bethesda 系统中删除“意义不明确的非典型/滤泡性病变”类别。
Am J Clin Pathol. 2011 Dec;136(6):896-902. doi: 10.1309/AJCPIX52MBOKTICP.
2
The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.意义不明确的非典型性/滤泡性病变及重复细针穿刺活检的影响:贝塞斯达系统实施前后5年
Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.
3
The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.应用亚分类和 BRAF 突变结果对甲状腺细胞病理学报告的 Bethesda 系统中“意义不明确的非典型性/滤泡性病变意义不明确”类别进行恶性风险预测。
Cancer Cytopathol. 2014 May;122(5):368-76. doi: 10.1002/cncy.21396. Epub 2014 Mar 3.
4
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
5
Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.甲状腺细针穿刺细胞学检查中不典型病变及意义未明的滤泡性病变的随访
Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18.
6
The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.不典型/意义不明的滤泡性病变对甲状腺细针抽吸恶性肿瘤发生率的影响:甲状腺细胞病理学报告的 Bethesda 系统评价。
Surgery. 2011 Dec;150(6):1234-41. doi: 10.1016/j.surg.2011.09.006.
7
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.不同的 AUS/FLUS 甲状腺细针穿刺活检的界限标准具有不同的 BRAF、RAS、RET/PTC 和 PAX8/PPARg 改变。
Cancer Cytopathol. 2018 May;126(5):317-325. doi: 10.1002/cncy.21984. Epub 2018 Feb 22.
8
The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.不明确意义的非典型性/滤泡性肿瘤不明确意义:恶性比例:在甲状腺细胞病理学 Bethesda 系统报告中建议的一项性能指标。
Cancer Cytopathol. 2012 Apr 25;120(2):111-6. doi: 10.1002/cncy.20192. Epub 2011 Sep 14.
9
The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.在甲状腺细针穿刺中使用贝塞斯达术语可降低非恶性结节的手术率:来自土耳其一家参考中心的报告。
Int J Surg Pathol. 2011 Dec;19(6):761-71. doi: 10.1177/1066896911415667. Epub 2011 Jul 26.
10
Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.在甲状腺细胞病理学报告的 Bethesda 系统中,对于诊断不明确或意义不明确的非典型性甲状腺结节,核心针活检比重复细针抽吸更有用。
Thyroid. 2012 May;22(5):468-75. doi: 10.1089/thy.2011.0185. Epub 2012 Feb 3.

引用本文的文献

1
Diagnostic utility of mutation testing for refining cytologically indeterminate thyroid nodules.用于细化细胞学检查结果不确定的甲状腺结节的突变检测的诊断效用
EXCLI J. 2024 Feb 15;23:283-299. doi: 10.17179/excli2024-6975. eCollection 2024.
2
Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.重复细针抽吸细胞学检查可优化甲状腺结节 Afirma 基因表达分类器检测的选择。
Thyroid. 2021 Aug;31(8):1253-1263. doi: 10.1089/thy.2020.0969. Epub 2021 Jun 22.
3
Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
当发现为恶性时,贝塞斯达III类甲状腺结节比贝塞斯达IV类甲状腺结节更具侵袭性吗?
Cancers (Basel). 2020 Sep 9;12(9):2563. doi: 10.3390/cancers12092563.
4
Thyroid Bethesda Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance (AUS/FLUS): A Heterogenous Group.甲状腺贝塞斯达意义未明的非典型病变或意义未明的滤泡性病变(AUS/FLUS):一个异质性群体。
J Cytol. 2019 Oct-Dec;36(4):200-204. doi: 10.4103/JOC.JOC_160_18. Epub 2019 Jun 11.
5
Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule.甲状腺结节的超声特征有助于解读贝塞斯达系统III/IV级甲状腺结节的恶性风险,并为治疗方案提供依据。
Diagn Cytopathol. 2019 Sep;47(9):881-889. doi: 10.1002/dc.24248. Epub 2019 Jun 18.
6
Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies.甲状腺细针穿刺标本不典型意义和滤泡性肿瘤可疑类别亚分类的恶性肿瘤风险。
Endocr Pathol. 2019 Jun;30(2):146-154. doi: 10.1007/s12022-019-9577-4.
7
Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology.对甲状腺结节选定超声特征的评估,这些结节具有意义不明确的非典型性/意义不明确的滤泡性病变,用于甲状腺细胞病理学的贝塞斯达报告系统。
Cancer Manag Res. 2018 Jul 23;10:2223-2229. doi: 10.2147/CMAR.S168409. eCollection 2018.
8
Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.甲状腺结节细胞诊断中异型性的限定词与不同的Afirma基因表达分类器结果及临床结局相关。
Cancer Cytopathol. 2017 May;125(5):313-322. doi: 10.1002/cncy.21827. Epub 2017 Feb 2.
9
Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology.从甲状腺细胞病理学报告的贝塞斯达系统角度看儿童甲状腺结节的细胞学诊断
J Cytol. 2016 Oct-Dec;33(4):220-223. doi: 10.4103/0970-9371.190451.
10
Fine Needle Aspiration in the Investigation of Thyroid Nodules.甲状腺结节检查中的细针穿刺抽吸术
Dtsch Arztebl Int. 2016 May 20;113(20):353-9. doi: 10.3238/arztebl.2016.0353.